Blood test tracking for testicular germ cell tumors
Part of Cancer clinical trials.
This study looks at whether a simple blood test (liquid biopsy) can help track germ cell tumors (testicular cancer). It may help doctors understand your disease better and guide your care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a male aged 18 or older.
- You must have been diagnosed with a germ cell tumor (a type of testicular cancer) that has spread, or you have stage I cancer that is high-risk and you are being monitored without extra treatment.
- You cannot have had any other cancer in the last 5 years (except a germ cell tumor).
- If you have stage I cancer, you cannot have received adjuvant chemotherapy or radiation after surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a blood test called miRNA-371 can detect active germ cell tumors in patients who have had surgery or are being watched. It may help guide treatment decisions without needing extra biopsies or scans.
This trial looks for signs of cancer DNA in your blood (circulating tumor DNA) to see if it can help track germ cell tumors. It may help doctors find out if your cancer is coming back earlier.
This study looks at whether levels of bile acids (substances made by your liver) can help doctors understand how testicular germ cell tumors grow and how they respond to treatment. It may help improve future care for people with this type of cancer.
This study looks at how to manage germ cell tumors in children and young adults using careful monitoring for some patients and chemotherapy for others. It aims to see whether these approaches can control the cancer while avoiding unnecessary treatment when possible.
This study looks at tiny molecules in your blood (called microRNAs) to see if they can help doctors identify and manage malignant ovarian germ cell tumors. By giving a blood sample at diagnosis, you may help improve future detection and treatment for this rare cancer.
This study uses a blood test (liquid biopsy) to look for tumor DNA in patients with advanced cancer. It aims to see if this test can help doctors monitor the cancer and make better treatment decisions.
Hear when a new 100 Stage I Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.